About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5905988
Allelic
Composition
Tg(KRT5-rtTA)#Glk/0
Tg(tetO-cre)1Jaw/0
Wnt10atm1Smr/Wnt10atm1Smr
Genetic
Background
involves: 129X1/SvJ * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT5-rtTA)#Glk mutation (0 available)
Tg(tetO-cre)1Jaw mutation (7 available)
Wnt10atm1Smr mutation (0 available); any Wnt10a mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
integument
• when treated with doxycycline at P25
• fail to extend when treated with doxycycline in early postnatal life
• regression of sweat glands when treated with doxycycline at P20
• elevated lipid production when treated with doxycycline at P25
• when treated with doxycycline at P20
• minitaturized when treated with doxycycline at P25
• delayed initiation of anagen until P29, when treated with doxycycline at P18
• premature when treated with doxycycline at P9
• however, hair follicle regression isnt observed when treated with doxycycline at P25
• slightly reduced proliferation when treated with doxycycline at P25

craniofacial
• flattened surface when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life

cellular
• decreased basal cell proliferation in the filiform papillae and plantar epithelium, fungiform and circumvallate taste buds and sweat buds when treated with doxycycline at in either the early postnatal period, or in adult life

taste/olfaction
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life

digestive/alimentary system
• flattened surface when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life

endocrine/exocrine glands
• when treated with doxycycline at P25
• fail to extend when treated with doxycycline in early postnatal life
• regression of sweat glands when treated with doxycycline at P20
• elevated lipid production when treated with doxycycline at P25
• when treated with doxycycline at P20

growth/size/body
• flattened surface when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• progressive from P7 when treated with doxycycline in early postnatal life
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory